Síndrome de Stevens–Johnson asociado a fenitoína en una paciente colombiana con síndrome convulsivo focal

Domínguez Domínguez, Camilo; Bonilla Briceño, Javier Fernando; Buitrago Marín, Claudia; Calderón Ospina, Carlos Alberto.
Med. UIS ; 25(2): 155-162, mayo-ago. 2012. tab, ilus
Artigo em Espanhol | LILACS | ID: lil-675052

Documentos relacionados

  1. Stevens-Johnson syndrome in children.
  2. Stevens-Johnson syndrome and toxic epidermal necrolysis from pathologist's point of view.
  3. Supportive care in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary Delphi-based consensus.
  4. EXAMINING THE ROLE OF THE NITRIC OXID SYSTEM AS THE ESSENTIAL PATHOGENETIC LINK IN STEVENS-JOHNSON SYNDROME.
  5. [Warning symptoms skin: cutaneous manifestation of drug allergy].
  6. Clinical and pathogenic aspects of the severe cutaneous adverse reaction epidermal necrolysis (EN).
  7. Drug-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Call for Optimum Patient Stratification and Theranostics via Pharmacogenomics.
  8. Cutaneous Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors and Their Management.
  9. Management of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Case Report and Literature Review.
  10. APOA4 as a novel predictor of prognosis in Stevens-Johnson syndrome/toxic epidermal necrolysis: A proteomics analysis from two prospective cohorts.